Cassava Sciences, Inc. (SAVA) stock is jumping high on 7.26% – Recent News
Cassava Sciences, Inc. (SAVA) has seen a push of 7.26% in the aftermarket because the company announced that petition filed by citizens on behalf of short-selling clients is denied by the FDA. However, the last trading session closed at $53.05 with an increase of 7.78%. FDA Denies Citizen Petitions – What’s happening? SAVA announced on […]
Trending 4 Stocks for Friday to Trade
U.S. stocks posted broad declines yesterday as investors grew cautious in the wake of Fed Chairman Jay Powell’s Wednesday comments on the economy and a weaker than expected jobless claims report. The S&P 500 declined 0.8% while the Nasdaq tumbled 1.2% and the Dow fell 0.4%. Asian stocks were mixed overnight, but the Chinese Shanghai […]
Cassava Sciences Stock Soared 130% on Monday Followed by Positive Results of New Alzheimer’s Phase 2 Trials
The biotech company Cassava Sciences updates that its Alzheimer’s drug, sumifilam, recorded positive results in treating Alzheimer’s patients in a phase 2 study. Cassava Sciences Inc. (SAVA) shares were on a roll in the last trading session on Monday after the company reported that it has obtained positive outcomes from its Phase 2 study of a […]